Navigation Links
UT researcher sheds new light on hybrid animals
Date:9/17/2007

alifornia Tiger salamander, which is native to the area of the study, is listed as threatened under the U.S. Endangered Species Act, while the Barred Tiger salamander is not. The data in the article lead the researchers to predict that eventually all California Tiger salamanders will have some of the non-native genes. In a sense, the entire species would then have hybrid ancestry.

According to Fitzpatrick, the finding raises questions about whether this would be considered beneficial to the native species or not -- it depends on how conservationists choose to define the new hybrid.

"If they consider it an acceptable modification of the original species, then this could enhance the chances for survival of the California Tiger salamander," he said, "but others may consider the hybrids to be genetically impure and see hybridization as accelerating extinction."

It is not yet clear from the research what is causing the hybrids to thrive.

"Our prediction is that, because of their advantages, the hybrids will remain part of the gene pool," said Fitzpatrick. "What we don't know is if those advantages come from the synergistic interaction of certain genes -- that they are greater than the sum of their parts -- or if they simply get the 'best of both worlds' by a selection of useful individual traits from each species."

Because the research is in such early stages, Fitzpatrick and colleagues plan to broaden their study of these salamanders, and also explore the implications of these vigorous hybrids for other animals in their ecosystem.

They have expanded the number of genetic markers that they are analyzing in the hybrids to determine the extent of their genetic mixing. Given that the new hybrids are finding more success in their environment, the researchers also plan to study whether their success is reducing food supply or other resources from native species in the area.

Fitzpatrick notes that their discoveries p
'/>"/>

Contact: Jay Mayfield
jay.mayfield@tennessee.edu
865-974-9409
University of Tennessee at Knoxville
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. U of M researcher examines newly emerging deadly disease
5. NYU researchers simulate molecular biological clock
6. Researchers reveal the infectious impact of salmon farms on wild salmon
7. Researchers identify target for cancer drugs
8. Vital step in cellular migration described by UCSD medical researchers
9. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
10. UCSD researchers maintain stem cells without contaminated animal feeder layers
11. Researchers discover molecule that causes secondary stroke

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ear record low in Antarctic snowmelt that occurred...to concurrent strong positive phases for two main ...on) and SAM (Southern Hemisphere Annular Mode), ac...of Earth & Atmospheric Sciences at The City Colleg...o on the doctoral faculty at the CUNY Graduate Cen...
(Date:12/2/2009)...ELPHIA Cigarette smoking and alcohol consumption ...dicts the patient,s future risk of death, accordin...y show a similar effect among those who continued ...cer survivors are counseled to quit smoking; despi...t continued to smoke even after their cancer diagn...
(Date:12/2/2009)...PHIA Assurance of a cancer-free status did not pr...zed tomography (CT) lung-cancer screening program ...te in a study published in Cancer Epidemiology, B... Association for Cancer Research. The December iss...findings should negate widespread concern in the l...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 1Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 2Eastern Insurance Holdings Inc to Release 2nd Quarter 2009 Financial Results 52603 3U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 1U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 2U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 3U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 4U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 5U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 6U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 7U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 8U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 9U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 10U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 11U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 12U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 13U S Expects 160 Million Doses of Swine Flu Vaccine by October 52598 14Registered Dietitian Reveals Chronic Back Pain Relief through Diet in New Book Cookbook and Diet Program 52595 1Registered Dietitian Reveals Chronic Back Pain Relief through Diet in New Book Cookbook and Diet Program 52595 2
...vere United States wildfires can contribute as muc...s, although the amount is highly variable. New res...Carbon Balance and Management quantifies these emi...s monitoring and modelling efforts. , Christine W...esearch and Jason Neff of the University of Colora...
...ADISON - Far removed from streams of gas-thirsty c...key player in global climate change. Circling the... forests - one of the largest ecosystems on earth ...arbon levels. , Forest ecologists at the Universi...ntal factors such as forest fires and climate infl...
...ethesda, MD - The November 1st and November 15th i...physical Society, are now available online. Topic...nels that could payoff in synthetic drug design, t...structure of a Na+/H+ antiporter dimmer. , Volu...the Kv1.2 voltage-gated K+ channel in a Membrane E...
Other Biology News:US faces burning emissions issue 2Wildfire drives carbon levels in northern forests 2Media highlights in the November issues of Biophysical Journal 2Media highlights in the November issues of Biophysical Journal 3
(Date:12/2/2009)...r 2 , - "Bolstering Biodi..." , Coinciding with the International Yea...blic is hosting an international conference in Lib...gical resources in Africa. The,conference will be ...s,scientific experts, private companies, represen...
(Date:12/2/2009)...wire/ -- S*BIO Pte Ltd today announced data presen...at The American Society of Hematology 51st Annual ...will be presented on the clinical results from the... its safety, tolerability and pharmacokinetic/phar... from 100 to 600 mg. These doses were administered...
(Date:12/2/2009)...wire-Asia/ -- The world is going through,extraordi... is part of many,businesses and industries. It tur...y immune to the economic downturn, because illness...dst of the difficult times this year, the pharmace...R&D center in Shanghai, the largest of,its kin...
(Date:12/1/2009)...RNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) ...for the fourth quarter ended December 31, 2009 of ...llion for the fourth quarter of 2008. Included in ...nstallment payments of $12.5 million from Alexion.... a one-time $1.8 million payment from Genentech fo...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...BEACH, Va., Feb. 5, 2009 AMERIGROUP Chairman and ...the following statement on legislation expanding t...P), which was signed yesterday by President Barack...healthy start in life, and that happens only when ...ealthcare they need. President Obama and Congress...
... ALEXANDRIA, Va., Feb. 5 As states increase the n... graduation, they are developing new ways of integ...ses to help students meet these requirements. One ...ort for the recognition of academic credit for car...aper released by the Association for Career and Te...
...tock Exchange Symbol: MS , , EDMONTON, Feb. 5 /PR..., a leading developer in the treatment of multiple...ese, President and CEO, will present at The 11th A...k. , , , WHEN: Monday February 9th at 2:45...ew York City, About BIO CEO & Investor Conf...
Other Biology Technology:AMERIGROUP Praises Expansion of State Children's Health Insurance Program (SCHIP) 2ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes 2ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes 3BioMS Medical to present at BIO CEO and Investor Conference 2
Anti-FLIPgamma / delta (CT) Antibody, Unconjugated from QED Bioscience Inc.
Mouse Anti-Vancomycin Monoclonal Antibody, Unconjugated, Clone 2G1 from Abcam
Rabbit Anti-Human Rab1A Antibody, Unconjugated from Spring Bioscience
Chicken Anti-Human LYZL6 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: